Manufacturing & Facilities
The company's plant is in the industrial area northwest of Iraq's capital, Baghdad, covering roughly 150,000 square metres.
150,000
Total plant area
approx. · As published by the company
Modern equipment, precise instruments
The plant is equipped with modern pharmaceutical manufacturing equipment and methods and precise technological instruments.
It brings together local and international specialists, selected to uphold operating and production standards, and supported by continuous training.

Manufacturing capabilities
The following capabilities are as described in the company's published materials:
Internationally recognised dosage forms
Production of multiple pharmaceutical forms for a range of therapeutic uses.
Freeze-dried injectables
Processing of injectable products by freeze-drying to extend stability.
Low-temperature processing
Processing of compounds at extremely low temperatures.
Licensed manufacturing
Production projects under licence with technology transfer.

Regulatory objective
The plant has been equipped with the aim that its products meet the requirements of the Iraqi pharmaceutical regulator, the US Food and Drug Administration, and pharmacopoeial specifications adopted in European countries.
This is a design objective stated by the company. It is not a statement that the plant or its products hold approval or certification from any authority.
How a medicine moves through a pharmaceutical plant
The general path a product follows from raw material to release:
- 01
Receiving materials
Active and inactive ingredients and packaging are received and held until the quality laboratory tests and approves them.
- 02
Weighing & preparation
Ingredients are weighed precisely against the formula in dedicated, environmentally controlled areas.
- 03
Manufacturing
The formulation is prepared under approved instructions, with controls that prevent contamination and ensure uniformity.
- 04
Filling & drying
The product is filled into its container, such as vials or solution bags, and freeze-dried where required.
- 05
Packaging & labelling
Containers are packed and labelled with product details, batch number and expiry date.
- 06
Testing & release
Batch samples are analysed and records reviewed before release to storage and distribution.
A general framework of common pharmaceutical practice, shown for illustration — not a description of the company's own procedures.
The production environments the plant's categories require

Sterile areas
Injectable products and IV solutions must be made in sterile environments with controlled air-cleanliness levels.
Segregated beta-lactam areas
Good manufacturing practice guidance calls for penicillin and cephalosporin production to be separated from other medicines.
Controlled storage
Materials and products are kept at temperatures and humidity that preserve their quality until use.
What is freeze-drying?
A process in which a product is frozen and its water then removed by sublimation under low pressure, leaving a stable powder that is reconstituted before use. It is used for heat- and moisture-sensitive injectables, and the company states its plant has capability for this type of injectable.

Illustrative footage from pharmaceutical production lines
Let's build a manufacturing partnership that lasts.
Whether you are looking for a manufacturing, development or distribution partner, we would be glad to talk.
- Phone
- +90 212 663 31 92
- Address
- Iraq — Baghdad — Industrial Area
